Regemat 3D
Regemat 3D
Website
HQ Country
Spain
Profile
REGEMAT 3D is a biotech company focused on regenerative medicine and pioneer in the use of 3D printing for regenerative therapies, a promising area called bioprinting. The potential of bioprinting in regenerative medicine and tissue engineering is huge. There are still many problems to be solved and many hypothesis to be tested in order to find solutions to tissue regeneration. Our mission is to develop customized innovative solutions in the area of bioprinting and regenerative medicine towards the clinical application of this amazing technology, aiming at improving people´s quality of life.
Filtered by:
Regemat 3D
Company
Topic
Show
2018
26 Jul 2018
Will bioprinting be an alternative to organ transplantation?
Bioprinting has emerged during the last years as a promising technology for creating living tissues to regenerate injuries and organs. Without any doubt it is a promising technology but, how far away scientists are from creating functional tissues and organs that can be implanted in human beings? Hype or reality?2017
13 Dec 2017
Report on IDTechEx Show! USA 2017
The following article summarises some of the key observations made by IDTechEx analysts during the IDTechEx Show! It contains details of many of the companies demonstrating products during the exhibition, notable presentations given and summaries of relevant conversations and recent updates.16 Nov 2017
3D Bioprinting : Advances In Cartilage Regeneration And Other Tissue Applications
Regemat 3D, Spain
19 Apr 2017
Regemat 3D
IDTechEx analyst Nadia Tsao interviewed Regemat 3D Business Development Manager Gloria Pinilla on April 19, 2017. Regemat 3D focuses on the development of 3D bioprinters for regenerative medicine.
Included are:
